Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Run-Lin Gao

Showing results (101-110 of 308) with videos related to

Pageof 31
Sort By:
International Urology and Nephrology|June 28, 2018
Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapyHong-Liang Xiong, Meng Peng, Xiong-Jing Jiang, et al.
Biomedical and Environmental Sciences : BES|July 10, 2020
Risk or Beneficial Factors Associated with Unplanned Revascularization Risk Following Percutaneous Coronary Intervention: A Large Single-Center DataRu Liu, Zhan Gao, Li Jian Gao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 28, 2003
Comparative effects of carvedilol and losartan alone and in combination for preventing left ventricular remodeling after acute myocardial infarction in ratsYue-Jin Yang, Yi-Da Tang, Ying-Mao Ruan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 19, 2009
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine heartsYue-Jin Yang, Hai-Yan Qian, Ji Huang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 24, 2018
Dual antiplatelet therapy after coronary drug-eluting stent implantation in China: A large single center studyJing-Jing Xu, Zhan Gao, Yin Zhang, et al.
The American Journal of Cardiology|March 26, 2017
Prognostic Value of the Clinical SYNTAX Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary InterventionChen He, Ying Song, Chuang-Shi Wang, et al.
Chinese Medical Journal|April 12, 2017
Long-term Outcomes of Primary Percutaneous Coronary Intervention with Second-generation Drug-eluting Stents in ST-elevation Myocardial Infarction Patients Caused by Very Late Stent ThrombosisChen He, Yuan-Liang Ma, Chuang-Shi Wang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 2, 2005
[Experimental study of Mytrolimus-eluting stents on preventing restenosis in porcine coronary model]Hong Qiu, Run-lin Gao, Zhi-rong Tang, et al.
Chinese Medical Journal|August 30, 2016
Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China StudyYue-Jin Yang, Yong Huo, Ya-Wei Xu, et al.
Journal of Interventional Cardiology|April 25, 2020
Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary SyndromeSi-Da Jia, Yi Yao, Ying Song, et al.
Pageof 31

Showing results (101-110 of 308) with videos related to

Sort By:
Pageof 31
International Urology and Nephrology|June 28, 2018
Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapyHong-Liang Xiong, Meng Peng, Xiong-Jing Jiang, et al.
Biomedical and Environmental Sciences : BES|July 10, 2020
Risk or Beneficial Factors Associated with Unplanned Revascularization Risk Following Percutaneous Coronary Intervention: A Large Single-Center DataRu Liu, Zhan Gao, Li Jian Gao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 28, 2003
Comparative effects of carvedilol and losartan alone and in combination for preventing left ventricular remodeling after acute myocardial infarction in ratsYue-Jin Yang, Yi-Da Tang, Ying-Mao Ruan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 19, 2009
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine heartsYue-Jin Yang, Hai-Yan Qian, Ji Huang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 24, 2018
Dual antiplatelet therapy after coronary drug-eluting stent implantation in China: A large single center studyJing-Jing Xu, Zhan Gao, Yin Zhang, et al.
The American Journal of Cardiology|March 26, 2017
Prognostic Value of the Clinical SYNTAX Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary InterventionChen He, Ying Song, Chuang-Shi Wang, et al.
Chinese Medical Journal|April 12, 2017
Long-term Outcomes of Primary Percutaneous Coronary Intervention with Second-generation Drug-eluting Stents in ST-elevation Myocardial Infarction Patients Caused by Very Late Stent ThrombosisChen He, Yuan-Liang Ma, Chuang-Shi Wang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 2, 2005
[Experimental study of Mytrolimus-eluting stents on preventing restenosis in porcine coronary model]Hong Qiu, Run-lin Gao, Zhi-rong Tang, et al.
Chinese Medical Journal|August 30, 2016
Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China StudyYue-Jin Yang, Yong Huo, Ya-Wei Xu, et al.
Journal of Interventional Cardiology|April 25, 2020
Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary SyndromeSi-Da Jia, Yi Yao, Ying Song, et al.
Pageof 31